Clinical Trials Directory

Trials / Conditions / Stage III Mucoepidermoid Carcinoma of the Oral Cavity

Stage III Mucoepidermoid Carcinoma of the Oral Cavity

10 registered clinical trials studyying Stage III Mucoepidermoid Carcinoma of the Oral Cavity — 1 currently recruiting.

StatusTrialSponsorPhase
CompletedAcetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoi
NCT02123511
Mayo ClinicPhase 2
TerminatedTransoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer
NCT01254734
City of Hope Medical CenterN/A
TerminatedEsophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radi
NCT01164566
Wake Forest University Health SciencesN/A
CompletedL-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For
NCT01155609
University of WashingtonN/A
RecruitingTransoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
NCT01473784
Ohio State University Comprehensive Cancer CenterN/A
CompletedBevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Pri
NCT00492089
National Cancer Institute (NCI)Phase 2
CompletedErlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidne
NCT00101348
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedAlvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors
NCT00089362
National Cancer Institute (NCI)Phase 1
CompletedBevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and
NCT00023959
National Cancer Institute (NCI)Phase 1
CompletedInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
National Cancer Institute (NCI)Phase 1